Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of recombinant von Willebrand factor (rVWF) in Chinese participants with von Willebrand disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• recombinant von Willebrand factor (rVWF) (recombinant von Willebrand factor (rVWF))

Snippet

Sponsor: Takeda | Conditions: Von Willebrand Disease (VWD) | Phase 3 | Status: RECRUITING